Elevance Health Inc. closed $174.10 below its 52-week high ($567.26), which the company achieved on September 3rd.
Wall Street was mixed in premarket trading on Thursday as major U.S. airlines stumbled and health insurance companies soared.
US stocks showed mixed signals in premarket trading on Thursday. Futures for the S&P 500 lost 0.1% before the opening bell, ...
U.S. stocks rose to a record Thursday as Wall Street regained some of the momentum that catapulted it to 57 all-time highs ...
In a report released today, David S Macdonald from Truist Financial reiterated a Buy rating on Elevance Health (ELV – Research Report), with a ...
Elevance Health (ELV – Research Report) received a Buy rating and a $485.00 price target from Cantor Fitzgerald analyst Sarah James yesterday.
Sources: FactSet, Dow Jones Stock Movers: Gainers, decliners and most actives market activity tables are a combination of NYSE, Nasdaq, NYSE American and NYSE Arca listings. Sources: FactSet ...
Shares of Elevance Health jumped early Thursday in response to better-than-expected fourth- quarter results, and a generally optimistic outlook for the coming year. A week after UnitedHealth Group ...
Shares of Elevance Health Inc. ELV slumped 0.69 ... with the S&P 500 Index SPX falling 1.11% to 5,970.84 and Dow Jones Industrial Average DJIA falling 0.77% to 42,992.21. The stock's fall snapped ...